Dr. Randeep Singh

Dr. Randeep Singh

Head of Department (HOD)

28 years of experience

Medical Oncologist

MBBS, MD, DM, FCCP

Reg. No.:32096, Delhi Medical Council

Dharamshila Narayana Superspeciality Hospital, New Delhi

English, Hindi, Punjabi

Consultation Fee ₹ 2000

Book an Appointment

About Dr. Randeep Singh

  • Dr. Randeep Singh is a renowned and experienced medical oncologist in Delhi with an impressive experience of 28 years.
  • He is trained and well-versed in dealing with solid and hematolymphoid tumors. He also specializes in different types of chemotherapy while providing precision oncology-based treatment.
  • Dr. Randeep Singh has vast experience with patients affected with cancer in the lungs, blood, breast, gastrointestinal tract, liver, pancreas, bile duct, and genitourinary tract.
  • He has expertise in offering cancerous treatments like
    • Target Therapy
    • Immunotherapy
    • Hormone Therapy
    • Biotherapy
    • Precision Oncology
  • Dr. Randeep Singh did an MBBS from Bharati Vidyapeeth Deemed University in 1996, and his specialization was DM in Medical Oncology at Tata Memorial Centre in 2008.
  • He also earned an MD in Pediatrics from S.N. Medical College, Jodhpur, Rajasthan University, in 2003.
  • Dr. Singh has been certified by the European Certified Medical Oncology (ECMO) and is a Fellow American Chest Physicians (FCCP).
  • He has been an active participant in quizzes where he won first and second positions. Further, he has multiple published papers.
  • Dr. Singh is associated with numerous organizations and is editor-in-chief of research journals. 

Education

  • MBBS - Bharati Vidyapeeth Deemed University, 1996
  • MD - Pediatrics - S.N. Medical College, Jodhpur, Rajasthan University, 2003
  • DM - Medical Oncology - Tata Memorial Centre, 2008
  • Fellow American Chest Physicians (FCCP)

Training & Certificates

  • European Certified Medical Oncology (ECMO)

Past Experience

  • Senior Consultant and Unit Head Medical Oncology at Artemis Hospital, Gururgram
  • Department of Medical Oncology at HCG Cancer Center, Delhi
  • Consultant Medical Oncologist at Max Group of Hospitals, Patparganj, 2015
  • Consultant Medical Oncologist at Tata Memorial Hospital, Mumbai, 2012
  • Senior Resident in Tata Memorial Hospital, 2011
  • Senior Residency in Pediatrics at PGIMER, Chandigarh

Awards

  • Second Position in Geriatric Oncology Case presentation from the Indian Cooperative Oncology Network in 2014
  • Second Position in Hematology Quiz at the National Level from Mumbai Hematology Group in 2011
  • First Position in Neonatology quiz at State Level from National Neonatology in 2006
  • First Position in Post-Graduate Quiz from Indian Academy Pediatrics at the State Level in 2006
  • Second Position in Paper Presentation from Indian Academy Pediatrics at State Levels in 2006
  • Received Distinction in Biochemistry, Surgery, and Ophthalmology from BVDU, Pune, during MBBS in 2000

Associations/Membership

  • International CME ORG
  • Indian Cooperative Oncology Network (ICON)
  • Delhi Oncology Forum
  • Indian Society of Medical & Pediatric Oncology (ISMPO)
  • Indian Academy of Pediatrics (IAP)
  • European Society of Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)

Paper Published

  • Parikh, P., Babu, G., Singh, R., Krishna, V., Bhatt, A., Bansal, I., ... & Rath, G. K. (2023). Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method. BMC cancer, 23(1), 714.
  • Parikh, P. M., & Singh, R. (2020). Why should we rely only on molecular tests based on Indian data? Int J Mol Immuno Oncol, 5, 44-46.
  • Parikh, P., & Singh, R. (2021). Hot race for COVID-19 vaccines–light at the end of the tunnel just got brighter. International Journal of Molecular and Immuno Oncology, 6(1), 1-3.
  • Parikh, P., Kapoor, A., Joshi, K., Bansal, I., Krishna, V., Sahoo, T. P., ... & Babu, K. G. (2021). Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian Association for Regional Cooperation Region. International Journal of Molecular & Immuno Oncology, 6(2), 61–65.
  • Singh, R., & Gupta, S. (2018). Small HER2 positive breast cancer: When is enough? Indian Journal of Medical and Paediatric Oncology, 39(01), 1–3.
  • Singh, R., & Rohtagi, N. (2017). Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India. South Asian Journal of Cancer, 6(04), 171-175.
  • Singh, R., Shirali, R., Chatterjee, S., Adhana, A., & Arora, R. S. (2016). Epidemiology of cancers among adolescents and young adults from a tertiary cancer center in Delhi. Indian Journal of Medical and Paediatric Oncology, 37(02), 90–94.

Field of Expertise

  • Adrenal Cancer Treatment
  • Bacillus Calmette Guerin (BCG) Therapy
  • Benign and Cancerous Tumor Excision
  • Bile Duct Cancer Treatment
  • Bone Marrow Transplant
  • Brain Tumor Surgery
  • Breast Biopsy
  • CAR T-Cell Therapy
  • Carcinoid Tumor Treatment
  • Castleman Disease Treatment
  • Chemotherapy
  • Colon Cancer Surgery
  • Completion Thyroidectomy
  • Endometrial Cancer Treatment
  • Endoscopic Tumor Removal
  • Ewing Family of Tumors Treatment
  • Fine Needle Aspiration
  • Genitourinary Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
  • Hormone Therapy
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Image-Guided Radiation Therapy (IGRT)
  • Immunotherapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Kaposi Sarcoma Treatment
  • Lumpectomy
  • Malignant Mesothelioma Treatment
  • Metastatic Tumor Treatment
  • Minimally Invasive Cancer Surgery
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Oncological Surgery
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • PET CT Scan
  • Proton Therapy
  • Radiation Therapy
  • Radioisotope Therapy
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Skin Lymphoma Treatment
  • Small Intestine Cancer Treatment
  • Targeted Therapy
  • Thymectomy
  • Thymoma and Thymic Carcinoma Treatment
  • Transarterial Chemoembolization (TACE)
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Whipple Procedure
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • Adrenocortical Carcinoma
  • Adult Hodgkins Lymphoma
  • AIDS-Related Cancer
  • Ameloblastoma
  • Anal Cancer
  • Anaplastic Carcinoma
  • Appendix Cancer
  • Atypical Hyperplasia
  • Atypical Spindle Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor (ATRT)
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Basal Cell Carcinoma of the Skin
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Bone Marrow Cancer
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Bronchial Tumors
  • Burkitt Lymphoma
  • Cancer in Children
  • Carcinoid Syndrome
  • Carcinoid Tumor (Gastrointestinal)
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myeloproliferative Neoplasms
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Desmoid Tumor
  • Ductal Carcinoma in Situ (DCIS)
  • Elevated PSA (Prostate-Specific Antigen) Level
  • Embryonal Tumors
  • Eosinophilia
  • Esophageal Cancer
  • Esophagectomy
  • Esthesioneuroblastoma
  • Estrogen Dependent Cancers
  • Ewing Sarcoma
  • Extracranial Germ Cell Tumor
  • Extragonadal Germ Cell Tumor
  • Extrahepatic Bile Duct Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Follicular Lymphoma
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Gallbladder Cancer
  • Gastric Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Gestational Trophoblastic Disease
  • Giant Cell Tumor
  • Gum Tumor
  • Hairy Cell Leukemia (HCL)
  • Head and Neck Cancer
  • Heart Cancer
  • Hepatocellular Cancer
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Hypopharyngeal Cancer
  • Immunotherapy
  • In-situ Breast Cancer
  • Incontinence After Prostate Surgery
  • Inflammatory Breast Cancer
  • Intensity Modulated Radiation Therapy
  • Intraocular Melanoma
  • Invasive Breast Cancer
  • Invasive Lobular Carcinoma
  • Islet Cell Tumor
  • Kaposi Sarcoma
  • Large Cell Carcinoma
  • Large Granular Lymphocytic (LGL) leukemia
  • Leukemia
  • Lip and Oral Cavity Cancer
  • Liver Cancer
  • Liver Cysts & Liver Tumors
  • Lung Cancer
  • Lymphatic Cancer
  • Lymphocytosis
  • Male Breast Cancer
  • Malignant Fibrous Histiocytoma (MFH)
  • Malignant Mesothelioma
  • Malignant Soft Tissue Tumors
  • Mediastinal Tumor
  • Medullary Carcinoma
  • Melanoma
  • Merkel Cell Carcinoma
  • Metastatic Cancer
  • Metastatic Spinal Tumors
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Metastatic Tumors
  • Mouth Cancer
  • Multiple Endocrine Neoplasia (MEN) Syndromes
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neuroendocrine Tumor
  • Non-Small Cell Lung Cancer
  • NUT Midline Carcinoma
  • Oncogenic Osteomalacia
  • Ophthalmic Cancer
  • Oral Cancer
  • Oropharyngeal Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Ovarian Germ Cell Tumors
  • Ovarian Primary Peritoneal Cancer
  • Ovarian Sex Cord Stromal Tumor
  • Pancreatic Cancer
  • Pancreatic Neuroendocrine Tumor
  • Paraganglioma
  • Paraneoplastic Syndromes
  • Parathyroid Cancer
  • Parotid Gland Tumor
  • Pediatric Chordomas
  • Pediatric Ependymoma
  • Pediatric Germ Cell Tumor
  • Pediatric Rhabdomyosarcoma
  • Pediatric Spinal Cord Tumor
  • Pediatric Spinal Tumor
  • Pediatric Vascular Tumors
  • Penile Cancer
  • Pharyngeal Cancer
  • Pheochromocytoma
  • Pigmented Villonodular Synovitis (PVNS)
  • Pineal Region Tumor
  • Plasma Cell Neoplasms
  • Pleural Tumor
  • Pleuropulmonary Blastoma
  • Prostate Cancer
  • PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
  • Pulmonary Nodules
  • Pure Red Cell Aplasia (PRCA)
  • Rectal Cancer
  • Recurrent Cancer
  • Relapsed ALL
  • Relapsed AML
  • Relapsed Multiple Myeloma
  • Renal Cell Cancer
  • Retinoblastoma (Cancer of the Eye)
  • Retroperitoneal Tumor
  • Rhabdomyosarcoma
  • Salivary Gland Cancer
  • Sarcoma
  • Sezary Syndrome
  • Skin Cancer
  • Skull Base Tumor
  • Small Cell Carcinoma
  • Small Cell Lung Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Spinal Tumor
  • Squamous Cell Carcinoma (SCC)
  • Stage 4 Cancer
  • Stomach Cancer
  • Sun Exposure & Skin Cancer
  • Synovial Sarcoma
  • Testicular Cancer
  • Throat Cancer
  • Thrombocytosis
  • Thymoma and Thymic Carcinoma
  • Thymus Gland Tumor
  • Thyroid Cancer
  • Tracheobronchial Tumor
  • Transitional Cell Cancer
  • Urethral Cancer
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vascular Tumor
  • Vulvar Cancer
  • Wilms Tumor

Now Request Doctor Appointment in Easy Steps